| Rachel Langford, OTR | |
|
1317 N 16th Ave, Durant, OK 74701-2134 | |
| (580) 740-0205 | |
| Not Available |
| Full Name | Rachel Langford |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1317 N 16th Ave, Durant, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013565126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 5377 (Oklahoma) | Primary |
| Provider Name | Janee Standifer Slp Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1598222051 PECOS PAC ID: 3375886534 Enrollment ID: O20190510001306 |
News Archive
Scientists have built a model that predicts how temperature affects the spread of Ross River virus, a common mosquito-borne virus in Australia, according to a report in the journal eLife.
Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today an agreement with Med Pro Associates of Colorado to serve as a non-exclusive independent sales and marketing representative to solicit sales, obtain orders and provide sales and marketing support for the company's line of products within the U.S.
People in Scotland's poorest areas are more likely to be affected by severe Covid-19 - and to die from the disease - than those in more affluent districts, according to a study of critical care units.
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, announces today that it has signed a collaboration agreement with Janssen Pharmaceutica N.V. for the discovery and development of drugs for the prophylaxis and treatment of dengue virus infection.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Langford, OTR 279 Eagle Loop Rd, Durant, OK 74701-8128 Ph: (580) 624-0550 | Rachel Langford, OTR 1317 N 16th Ave, Durant, OK 74701-2134 Ph: (580) 740-0205 |
News Archive
Scientists have built a model that predicts how temperature affects the spread of Ross River virus, a common mosquito-borne virus in Australia, according to a report in the journal eLife.
Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today an agreement with Med Pro Associates of Colorado to serve as a non-exclusive independent sales and marketing representative to solicit sales, obtain orders and provide sales and marketing support for the company's line of products within the U.S.
People in Scotland's poorest areas are more likely to be affected by severe Covid-19 - and to die from the disease - than those in more affluent districts, according to a study of critical care units.
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, announces today that it has signed a collaboration agreement with Janssen Pharmaceutica N.V. for the discovery and development of drugs for the prophylaxis and treatment of dengue virus infection.
› Verified 5 days ago
Innovations Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 608 Bryan Dr, Durant, OK 74701 Phone: 214-537-2344 | |
Heather Gleaton, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 523 W Main St, Durant, OK 74701 Phone: 580-924-7701 | |
Inventive Therapy Services, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2620 Maxey Dr, Durant, OK 74701 Phone: 580-775-0699 | |
Janet Ballard, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 N Washington Ave, Durant, OK 74701 Phone: 580-740-0205 | |
John Hunter Palesano, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 N Washington Ave, Durant, OK 74701 Phone: 580-740-0205 Fax: 580-634-2848 | |
Ashley Ralston, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5019 Kimber Ln, Durant, OK 74701 Phone: 580-775-1988 |